• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar for Nov. 26-30

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Andrew von Eschenbach, Commissioner, Food and Drugs11/27/07Silver Spring, MDStephen Mason, Deborah Autor, Jeremiah Kelly, Jennifer Divine, Mike LevyU.S. Representative Marion Berry, U.S. Representative Mike Ross, Bob Russell (Office of U.S. Senator Pryor)Unapproved Hydrocodone products
Andrew von Eschenbach, Commissioner, Food and Drugs11/28/07Atlanta, GARandall Lutter, Faye Feldstein, Jesse Goodman, Boris Lushniak, Robert Ali, Irene Chan, Morris Potter, Steve SolominN/ACenter for Disease Control/FDA Leadership Forum
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer11/26/07 through 11/30/07N/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs11/28/07Brussels, BelgiumJustina Molzon, Michelle Limoli, Nicholas Buhay, Joan BlairRepresentatives of U.S. and European Union (EU) industry group, and regulators from the EU, European Commission, and the European Medicines AgencyAdministrative Simplification Workshop
Murray Lumpkin, Deputy Commissioner for International and Special Programs11/29/07London, EnglandN/AMembers of the Royal College of Pharmaceutical MedicineSpeech at the  Annual Meeting of the Royal College of Pharmaceutical Physicians on U.S. Pediatric Initiatives
Murray Lumpkin, Deputy Commissioner for International and Special Programs11/30/07London, EnglandN/ASir Alasdair Breckenridge (Medicines and Healthcare products Regulatory Agency), Ragnar Löfstedt (The King's Centre for Risk Management at the University of London)Risk management tools and possibilities
Randall Lutter, Deputy Commissioner for Policy 11/27/07Washington, DCMalcolm Bertoni, Irene ChanNational Academy of Sciences membersRisk ranking project
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs, Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research 1/29/07Bangkok, Thailand N/A N/ASpeech on Personalized Medicine at The Sixth Princess Chulabhorn International Science Congress
Margaret Glavin, Associate Commissioner, Office of Regulatory Affairs11/26/07 through 11/30/07N/AN/AN/ANo significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research11/26/07 through 11/30/07N/AN/AN/ANo significant meetings
Daniel Schultz, Director, Center for Devices and Radiological Health11/28/07Rockville, MDJeffrey SengerEamonn Hobbs (AngioDynamics).  Jodie Low and Jeffrey Kimbell (Jeffrey J. Kimbell & Associates)Device issues
David Acheson, Acting Director, Center for Food Safety and Applied Nutrition11/26/07 through 11/30/07N/AN/AN/ANo significant meetings
Stephen Sundlof, Director, Center for Veterinary Medicine11/28/07Rockville, MDBernadette Dunham, William Flynn, Martine Hartogensis, Sharon Benz, Lynn PostBill Bookout and Dale Metz (National Animal Supplement Council)Meet and greet
Stephen Sundlof, Director, Center for Veterinary Medicine11/30/07Rockville, MDMerton Smith, Shannon Jordre, Burt PritchettYoichi Watanabe and Noboru Kawamoto (Embassy of Japan)Update on Feed Ban rule.
William Slikker, Director, National Center for Toxicological Research11/26/07 through 11/30/07N/AN/AN/ANo significant meetings
Gerald Masoudi, Chief Counsel11/26/07Rockville, MDJeff Senger, Ann Wion, Laura EpsteinNancy Cahill (Aim Group), Randy Scott and Kim Popovits (Genomic Health), Paul Thompson and Paul Radensky (McDermott, Will & Emory), Jeffrey Gibbs (Hyman, Phelps, McNamara)Genomic Health, Inc.'s In Vitro Diagnostic Multivariate Index Assays (IVDMIA) document
Gerald Masoudi, Chief Counsel11/27/07Washington, DCJeff Senger, Scott, DanzisPharmaceutical Research and Manufacturers of America (PhRMA)  membersRegulatory Issues